nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—CYP2C9—brain cancer	0.807	1	CbGaD
Candesartan—PTGS1—Etoposide—brain cancer	0.0272	0.508	CbGbCtD
Candesartan—CYP2C8—Etoposide—brain cancer	0.0157	0.293	CbGbCtD
Candesartan—ABCB1—Etoposide—brain cancer	0.0106	0.198	CbGbCtD
Candesartan—Pranlukast—CYP2C9—brain cancer	0.00207	0.353	CrCbGaD
Candesartan—Transaminases increased—Carmustine—brain cancer	0.00192	0.0185	CcSEcCtD
Candesartan—Nephropathy—Etoposide—brain cancer	0.0019	0.0183	CcSEcCtD
Candesartan—Valsartan—CYP2C9—brain cancer	0.00169	0.288	CrCbGaD
Candesartan—Renal failure—Lomustine—brain cancer	0.00162	0.0156	CcSEcCtD
Candesartan—Hyperuricaemia—Hydroxyurea—brain cancer	0.00156	0.015	CcSEcCtD
Candesartan—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00154	0.0745	CbGpPWpGaD
Candesartan—Haemoglobin—Lomustine—brain cancer	0.00149	0.0143	CcSEcCtD
Candesartan—Haemorrhage—Lomustine—brain cancer	0.00148	0.0142	CcSEcCtD
Candesartan—Blood uric acid increased—Hydroxyurea—brain cancer	0.00147	0.0142	CcSEcCtD
Candesartan—Coagulopathy—Temozolomide—brain cancer	0.00145	0.014	CcSEcCtD
Candesartan—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00139	0.0669	CbGpPWpGaD
Candesartan—Blood urea increased—Hydroxyurea—brain cancer	0.00137	0.0132	CcSEcCtD
Candesartan—PTGS1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.0013	0.0627	CbGpPWpGaD
Candesartan—Irbesartan—CYP2C9—brain cancer	0.00128	0.218	CrCbGaD
Candesartan—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00126	0.0609	CbGpPWpGaD
Candesartan—UGT1A3—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00126	0.0607	CbGpPWpGaD
Candesartan—Leukopenia—Lomustine—brain cancer	0.00115	0.0111	CcSEcCtD
Candesartan—Angina pectoris—Procarbazine—brain cancer	0.00114	0.011	CcSEcCtD
Candesartan—Sweating increased—Procarbazine—brain cancer	0.00114	0.011	CcSEcCtD
Candesartan—AGTR1—endothelium—brain cancer	0.00111	0.12	CbGeAlD
Candesartan—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00107	0.0519	CbGpPWpGaD
Candesartan—Thrombocytopenia—Lomustine—brain cancer	0.00103	0.00991	CcSEcCtD
Candesartan—AGTR1—blood vessel—brain cancer	0.00103	0.111	CbGeAlD
Candesartan—Haematuria—Procarbazine—brain cancer	0.000997	0.0096	CcSEcCtD
Candesartan—Epistaxis—Procarbazine—brain cancer	0.000986	0.0095	CcSEcCtD
Candesartan—Blood creatinine increased—Hydroxyurea—brain cancer	0.000984	0.00948	CcSEcCtD
Candesartan—Hyperuricaemia—Etoposide—brain cancer	0.000975	0.00939	CcSEcCtD
Candesartan—Body temperature increased—Carboplatin—brain cancer	0.000949	0.00914	CcSEcCtD
Candesartan—Haemoglobin—Procarbazine—brain cancer	0.000944	0.00909	CcSEcCtD
Candesartan—Haemorrhage—Procarbazine—brain cancer	0.000939	0.00904	CcSEcCtD
Candesartan—Gastroenteritis—Temozolomide—brain cancer	0.000926	0.00891	CcSEcCtD
Candesartan—Blood uric acid increased—Etoposide—brain cancer	0.000921	0.00887	CcSEcCtD
Candesartan—PTGS1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.0009	0.0434	CbGpPWpGaD
Candesartan—Hyponatraemia—Carmustine—brain cancer	0.000853	0.00821	CcSEcCtD
Candesartan—Neutropenia—Hydroxyurea—brain cancer	0.000849	0.00817	CcSEcCtD
Candesartan—Body temperature increased—Lomustine—brain cancer	0.000831	0.008	CcSEcCtD
Candesartan—Losartan—CYP2C9—brain cancer	0.000825	0.141	CrCbGaD
Candesartan—Anaemia—Procarbazine—brain cancer	0.000755	0.00727	CcSEcCtD
Candesartan—UGT1A3—endocrine gland—brain cancer	0.000737	0.0793	CbGeAlD
Candesartan—Leukopenia—Procarbazine—brain cancer	0.000732	0.00704	CcSEcCtD
Candesartan—Haemoglobin—Hydroxyurea—brain cancer	0.00073	0.00703	CcSEcCtD
Candesartan—Haemorrhage—Hydroxyurea—brain cancer	0.000727	0.007	CcSEcCtD
Candesartan—Cardiac failure congestive—Etoposide—brain cancer	0.000724	0.00697	CcSEcCtD
Candesartan—Cough—Procarbazine—brain cancer	0.000713	0.00687	CcSEcCtD
Candesartan—Hypertension—Procarbazine—brain cancer	0.000706	0.00679	CcSEcCtD
Candesartan—Myalgia—Procarbazine—brain cancer	0.000696	0.0067	CcSEcCtD
Candesartan—Arthralgia—Procarbazine—brain cancer	0.000696	0.0067	CcSEcCtD
Candesartan—Anxiety—Procarbazine—brain cancer	0.000693	0.00668	CcSEcCtD
Candesartan—Sweating increased—Temozolomide—brain cancer	0.000691	0.00665	CcSEcCtD
Candesartan—Neutropenia—Carmustine—brain cancer	0.000686	0.00661	CcSEcCtD
Candesartan—Bronchitis—Temozolomide—brain cancer	0.000682	0.00657	CcSEcCtD
Candesartan—Cardiac failure—Etoposide—brain cancer	0.000673	0.00648	CcSEcCtD
Candesartan—Vomiting—Lomustine—brain cancer	0.000668	0.00643	CcSEcCtD
Candesartan—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000666	0.0322	CbGpPWpGaD
Candesartan—Neutropenia—Temozolomide—brain cancer	0.000663	0.00639	CcSEcCtD
Candesartan—Hyperglycaemia—Carmustine—brain cancer	0.000662	0.00637	CcSEcCtD
Candesartan—Upper respiratory tract infection—Temozolomide—brain cancer	0.000659	0.00635	CcSEcCtD
Candesartan—Thrombocytopenia—Procarbazine—brain cancer	0.000653	0.00629	CcSEcCtD
Candesartan—Tachycardia—Procarbazine—brain cancer	0.000651	0.00627	CcSEcCtD
Candesartan—Hyperhidrosis—Procarbazine—brain cancer	0.000645	0.00621	CcSEcCtD
Candesartan—Renal failure—Carmustine—brain cancer	0.000643	0.00619	CcSEcCtD
Candesartan—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000641	0.0309	CbGpPWpGaD
Candesartan—Hyperglycaemia—Temozolomide—brain cancer	0.00064	0.00616	CcSEcCtD
Candesartan—Nausea—Lomustine—brain cancer	0.000624	0.00601	CcSEcCtD
Candesartan—Hypotension—Procarbazine—brain cancer	0.000623	0.006	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000608	0.00585	CcSEcCtD
Candesartan—Paraesthesia—Procarbazine—brain cancer	0.000599	0.00577	CcSEcCtD
Candesartan—Sinusitis—Temozolomide—brain cancer	0.000593	0.00571	CcSEcCtD
Candesartan—Somnolence—Procarbazine—brain cancer	0.000593	0.00571	CcSEcCtD
Candesartan—Haemoglobin—Carmustine—brain cancer	0.00059	0.00568	CcSEcCtD
Candesartan—Haemorrhage—Carmustine—brain cancer	0.000587	0.00566	CcSEcCtD
Candesartan—Anaemia—Hydroxyurea—brain cancer	0.000585	0.00563	CcSEcCtD
Candesartan—Oedema peripheral—Carmustine—brain cancer	0.000579	0.00557	CcSEcCtD
Candesartan—Fatigue—Procarbazine—brain cancer	0.000575	0.00554	CcSEcCtD
Candesartan—Haemoglobin—Temozolomide—brain cancer	0.000571	0.00549	CcSEcCtD
Candesartan—Haemorrhage—Temozolomide—brain cancer	0.000568	0.00547	CcSEcCtD
Candesartan—Hepatitis—Temozolomide—brain cancer	0.000568	0.00547	CcSEcCtD
Candesartan—PTGS1—ganglion—brain cancer	0.000567	0.0611	CbGeAlD
Candesartan—Leukopenia—Hydroxyurea—brain cancer	0.000566	0.00545	CcSEcCtD
Candesartan—Pharyngitis—Temozolomide—brain cancer	0.000563	0.00542	CcSEcCtD
Candesartan—Urinary tract disorder—Temozolomide—brain cancer	0.000561	0.0054	CcSEcCtD
Candesartan—Oedema peripheral—Temozolomide—brain cancer	0.000559	0.00538	CcSEcCtD
Candesartan—Urethral disorder—Temozolomide—brain cancer	0.000556	0.00536	CcSEcCtD
Candesartan—Sweating increased—Etoposide—brain cancer	0.000553	0.00532	CcSEcCtD
Candesartan—Gastrointestinal pain—Procarbazine—brain cancer	0.000545	0.00525	CcSEcCtD
Candesartan—Neutropenia—Etoposide—brain cancer	0.000531	0.00511	CcSEcCtD
Candesartan—Urticaria—Procarbazine—brain cancer	0.00053	0.0051	CcSEcCtD
Candesartan—Body temperature increased—Procarbazine—brain cancer	0.000527	0.00508	CcSEcCtD
Candesartan—Abdominal pain—Procarbazine—brain cancer	0.000527	0.00508	CcSEcCtD
Candesartan—Mental disorder—Carmustine—brain cancer	0.000515	0.00496	CcSEcCtD
Candesartan—Malnutrition—Carmustine—brain cancer	0.000511	0.00492	CcSEcCtD
Candesartan—Thrombocytopenia—Hydroxyurea—brain cancer	0.000505	0.00487	CcSEcCtD
Candesartan—Acute coronary syndrome—Etoposide—brain cancer	0.000499	0.0048	CcSEcCtD
Candesartan—Renal failure—Etoposide—brain cancer	0.000497	0.00479	CcSEcCtD
Candesartan—Mental disorder—Temozolomide—brain cancer	0.000497	0.00479	CcSEcCtD
Candesartan—Myocardial infarction—Etoposide—brain cancer	0.000496	0.00478	CcSEcCtD
Candesartan—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000495	0.0239	CbGpPWpGaD
Candesartan—Back pain—Carmustine—brain cancer	0.000495	0.00476	CcSEcCtD
Candesartan—Malnutrition—Temozolomide—brain cancer	0.000494	0.00476	CcSEcCtD
Candesartan—PTGS1—endothelium—brain cancer	0.000489	0.0527	CbGeAlD
Candesartan—Asthenia—Procarbazine—brain cancer	0.000479	0.00461	CcSEcCtD
Candesartan—Back pain—Temozolomide—brain cancer	0.000478	0.0046	CcSEcCtD
Candesartan—Anaemia—Carmustine—brain cancer	0.000473	0.00455	CcSEcCtD
Candesartan—Agranulocytosis—Etoposide—brain cancer	0.000472	0.00455	CcSEcCtD
Candesartan—Pruritus—Procarbazine—brain cancer	0.000472	0.00454	CcSEcCtD
Candesartan—Dyspnoea—Hydroxyurea—brain cancer	0.00046	0.00443	CcSEcCtD
Candesartan—Somnolence—Hydroxyurea—brain cancer	0.000459	0.00442	CcSEcCtD
Candesartan—Leukopenia—Carmustine—brain cancer	0.000458	0.00441	CcSEcCtD
Candesartan—Anaemia—Temozolomide—brain cancer	0.000457	0.0044	CcSEcCtD
Candesartan—Diarrhoea—Procarbazine—brain cancer	0.000456	0.00439	CcSEcCtD
Candesartan—Dyspepsia—Hydroxyurea—brain cancer	0.000454	0.00438	CcSEcCtD
Candesartan—Angioedema—Temozolomide—brain cancer	0.000452	0.00435	CcSEcCtD
Candesartan—PTGS1—blood vessel—brain cancer	0.000451	0.0486	CbGeAlD
Candesartan—Urinary tract disorder—Etoposide—brain cancer	0.000449	0.00432	CcSEcCtD
Candesartan—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000446	0.00429	CcSEcCtD
Candesartan—Urethral disorder—Etoposide—brain cancer	0.000445	0.00429	CcSEcCtD
Candesartan—Fatigue—Hydroxyurea—brain cancer	0.000445	0.00429	CcSEcCtD
Candesartan—Vertigo—Temozolomide—brain cancer	0.000444	0.00428	CcSEcCtD
Candesartan—Leukopenia—Temozolomide—brain cancer	0.000442	0.00426	CcSEcCtD
Candesartan—Hypertension—Carmustine—brain cancer	0.000441	0.00425	CcSEcCtD
Candesartan—Dizziness—Procarbazine—brain cancer	0.000441	0.00425	CcSEcCtD
Candesartan—Palpitations—Temozolomide—brain cancer	0.000437	0.0042	CcSEcCtD
Candesartan—Chest pain—Carmustine—brain cancer	0.000435	0.00419	CcSEcCtD
Candesartan—Myalgia—Carmustine—brain cancer	0.000435	0.00419	CcSEcCtD
Candesartan—Anxiety—Carmustine—brain cancer	0.000434	0.00418	CcSEcCtD
Candesartan—Cough—Temozolomide—brain cancer	0.000431	0.00415	CcSEcCtD
Candesartan—Hypertension—Temozolomide—brain cancer	0.000427	0.00411	CcSEcCtD
Candesartan—Vomiting—Procarbazine—brain cancer	0.000424	0.00408	CcSEcCtD
Candesartan—Myalgia—Temozolomide—brain cancer	0.000421	0.00405	CcSEcCtD
Candesartan—Arthralgia—Temozolomide—brain cancer	0.000421	0.00405	CcSEcCtD
Candesartan—Rash—Procarbazine—brain cancer	0.000421	0.00405	CcSEcCtD
Candesartan—Dermatitis—Procarbazine—brain cancer	0.00042	0.00405	CcSEcCtD
Candesartan—Anxiety—Temozolomide—brain cancer	0.000419	0.00404	CcSEcCtD
Candesartan—Headache—Procarbazine—brain cancer	0.000418	0.00402	CcSEcCtD
Candesartan—Thrombocytopenia—Carmustine—brain cancer	0.000409	0.00393	CcSEcCtD
Candesartan—Body temperature increased—Hydroxyurea—brain cancer	0.000408	0.00393	CcSEcCtD
Candesartan—Tachycardia—Carmustine—brain cancer	0.000407	0.00392	CcSEcCtD
Candesartan—AGTR1—pituitary gland—brain cancer	0.000405	0.0437	CbGeAlD
Candesartan—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000398	0.0192	CbGpPWpGaD
Candesartan—Nausea—Procarbazine—brain cancer	0.000396	0.00382	CcSEcCtD
Candesartan—Thrombocytopenia—Temozolomide—brain cancer	0.000395	0.0038	CcSEcCtD
Candesartan—AGTR1—medulla oblongata—brain cancer	0.000391	0.0421	CbGeAlD
Candesartan—Hypotension—Carmustine—brain cancer	0.00039	0.00375	CcSEcCtD
Candesartan—Hyperhidrosis—Temozolomide—brain cancer	0.00039	0.00375	CcSEcCtD
Candesartan—Back pain—Etoposide—brain cancer	0.000382	0.00368	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Carmustine—brain cancer	0.00038	0.00366	CcSEcCtD
Candesartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00038	0.0183	CbGpPWpGaD
Candesartan—Paraesthesia—Carmustine—brain cancer	0.000375	0.00361	CcSEcCtD
Candesartan—Dyspnoea—Carmustine—brain cancer	0.000372	0.00358	CcSEcCtD
Candesartan—Somnolence—Carmustine—brain cancer	0.000371	0.00357	CcSEcCtD
Candesartan—Asthenia—Hydroxyurea—brain cancer	0.00037	0.00357	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000367	0.00354	CcSEcCtD
Candesartan—Anaemia—Etoposide—brain cancer	0.000365	0.00352	CcSEcCtD
Candesartan—Paraesthesia—Temozolomide—brain cancer	0.000362	0.00349	CcSEcCtD
Candesartan—Gastrointestinal disorder—Carmustine—brain cancer	0.00036	0.00347	CcSEcCtD
Candesartan—Dyspnoea—Temozolomide—brain cancer	0.00036	0.00346	CcSEcCtD
Candesartan—Somnolence—Temozolomide—brain cancer	0.000359	0.00345	CcSEcCtD
Candesartan—Vertigo—Etoposide—brain cancer	0.000355	0.00342	CcSEcCtD
Candesartan—Dyspepsia—Temozolomide—brain cancer	0.000355	0.00342	CcSEcCtD
Candesartan—Leukopenia—Etoposide—brain cancer	0.000354	0.00341	CcSEcCtD
Candesartan—Diarrhoea—Hydroxyurea—brain cancer	0.000353	0.0034	CcSEcCtD
Candesartan—Gastrointestinal disorder—Temozolomide—brain cancer	0.000348	0.00335	CcSEcCtD
Candesartan—Fatigue—Temozolomide—brain cancer	0.000348	0.00335	CcSEcCtD
Candesartan—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000347	0.0168	CbGpPWpGaD
Candesartan—Cough—Etoposide—brain cancer	0.000345	0.00332	CcSEcCtD
Candesartan—Hypertension—Etoposide—brain cancer	0.000341	0.00329	CcSEcCtD
Candesartan—Dizziness—Hydroxyurea—brain cancer	0.000341	0.00329	CcSEcCtD
Candesartan—Gastrointestinal pain—Carmustine—brain cancer	0.000341	0.00329	CcSEcCtD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000338	0.0163	CbGpPWpGaD
Candesartan—Chest pain—Etoposide—brain cancer	0.000337	0.00324	CcSEcCtD
Candesartan—Abdominal pain—Carmustine—brain cancer	0.00033	0.00318	CcSEcCtD
Candesartan—Body temperature increased—Carmustine—brain cancer	0.00033	0.00318	CcSEcCtD
Candesartan—Gastrointestinal pain—Temozolomide—brain cancer	0.00033	0.00318	CcSEcCtD
Candesartan—Vomiting—Hydroxyurea—brain cancer	0.000328	0.00316	CcSEcCtD
Candesartan—UGT1A3—Biological oxidations—CYP2C9—brain cancer	0.000327	0.0158	CbGpPWpGaD
Candesartan—Rash—Hydroxyurea—brain cancer	0.000325	0.00313	CcSEcCtD
Candesartan—Dermatitis—Hydroxyurea—brain cancer	0.000325	0.00313	CcSEcCtD
Candesartan—Headache—Hydroxyurea—brain cancer	0.000323	0.00311	CcSEcCtD
Candesartan—UGT1A3—Metapathway biotransformation—CYP2C9—brain cancer	0.000323	0.0156	CbGpPWpGaD
Candesartan—Urticaria—Temozolomide—brain cancer	0.00032	0.00309	CcSEcCtD
Candesartan—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00032	0.0155	CbGpPWpGaD
Candesartan—Body temperature increased—Temozolomide—brain cancer	0.000319	0.00307	CcSEcCtD
Candesartan—Abdominal pain—Temozolomide—brain cancer	0.000319	0.00307	CcSEcCtD
Candesartan—Thrombocytopenia—Etoposide—brain cancer	0.000316	0.00304	CcSEcCtD
Candesartan—Tachycardia—Etoposide—brain cancer	0.000315	0.00303	CcSEcCtD
Candesartan—AGTR1—endocrine gland—brain cancer	0.000314	0.0338	CbGeAlD
Candesartan—Hyperhidrosis—Etoposide—brain cancer	0.000312	0.003	CcSEcCtD
Candesartan—AGTR1—head—brain cancer	0.00031	0.0334	CbGeAlD
Candesartan—Nausea—Hydroxyurea—brain cancer	0.000307	0.00295	CcSEcCtD
Candesartan—Hypotension—Etoposide—brain cancer	0.000302	0.0029	CcSEcCtD
Candesartan—Asthenia—Carmustine—brain cancer	0.000299	0.00288	CcSEcCtD
Candesartan—Paraesthesia—Etoposide—brain cancer	0.00029	0.00279	CcSEcCtD
Candesartan—Asthenia—Temozolomide—brain cancer	0.000289	0.00279	CcSEcCtD
Candesartan—Dyspnoea—Etoposide—brain cancer	0.000288	0.00277	CcSEcCtD
Candesartan—Somnolence—Etoposide—brain cancer	0.000287	0.00276	CcSEcCtD
Candesartan—Diarrhoea—Carmustine—brain cancer	0.000286	0.00275	CcSEcCtD
Candesartan—Pruritus—Temozolomide—brain cancer	0.000285	0.00275	CcSEcCtD
Candesartan—AGTR1—central nervous system—brain cancer	0.000283	0.0305	CbGeAlD
Candesartan—Gastrointestinal disorder—Etoposide—brain cancer	0.000279	0.00268	CcSEcCtD
Candesartan—Fatigue—Etoposide—brain cancer	0.000278	0.00268	CcSEcCtD
Candesartan—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000277	0.0134	CbGpPWpGaD
Candesartan—Dizziness—Carmustine—brain cancer	0.000276	0.00266	CcSEcCtD
Candesartan—Diarrhoea—Temozolomide—brain cancer	0.000276	0.00266	CcSEcCtD
Candesartan—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000273	0.0132	CbGpPWpGaD
Candesartan—ABCB1—blood vessel—brain cancer	0.000267	0.0287	CbGeAlD
Candesartan—Dizziness—Temozolomide—brain cancer	0.000267	0.00257	CcSEcCtD
Candesartan—Vomiting—Carmustine—brain cancer	0.000265	0.00256	CcSEcCtD
Candesartan—Gastrointestinal pain—Etoposide—brain cancer	0.000264	0.00254	CcSEcCtD
Candesartan—Rash—Carmustine—brain cancer	0.000263	0.00253	CcSEcCtD
Candesartan—Dermatitis—Carmustine—brain cancer	0.000263	0.00253	CcSEcCtD
Candesartan—Headache—Carmustine—brain cancer	0.000261	0.00252	CcSEcCtD
Candesartan—Vomiting—Temozolomide—brain cancer	0.000256	0.00247	CcSEcCtD
Candesartan—Urticaria—Etoposide—brain cancer	0.000256	0.00247	CcSEcCtD
Candesartan—Body temperature increased—Etoposide—brain cancer	0.000255	0.00246	CcSEcCtD
Candesartan—Abdominal pain—Etoposide—brain cancer	0.000255	0.00246	CcSEcCtD
Candesartan—Rash—Temozolomide—brain cancer	0.000254	0.00245	CcSEcCtD
Candesartan—Dermatitis—Temozolomide—brain cancer	0.000254	0.00245	CcSEcCtD
Candesartan—Headache—Temozolomide—brain cancer	0.000253	0.00243	CcSEcCtD
Candesartan—Nausea—Carmustine—brain cancer	0.000248	0.00239	CcSEcCtD
Candesartan—Nausea—Temozolomide—brain cancer	0.00024	0.00231	CcSEcCtD
Candesartan—Asthenia—Etoposide—brain cancer	0.000232	0.00223	CcSEcCtD
Candesartan—Pruritus—Etoposide—brain cancer	0.000228	0.0022	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—PDGFRA—brain cancer	0.000225	0.0109	CbGpPWpGaD
Candesartan—AGTR1—brain—brain cancer	0.000225	0.0242	CbGeAlD
Candesartan—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000224	0.0108	CbGpPWpGaD
Candesartan—Diarrhoea—Etoposide—brain cancer	0.000221	0.00213	CcSEcCtD
Candesartan—CYP2C8—pituitary gland—brain cancer	0.00022	0.0237	CbGeAlD
Candesartan—PTGS1—telencephalon—brain cancer	0.000219	0.0236	CbGeAlD
Candesartan—Dizziness—Etoposide—brain cancer	0.000213	0.00205	CcSEcCtD
Candesartan—Vomiting—Etoposide—brain cancer	0.000205	0.00198	CcSEcCtD
Candesartan—Rash—Etoposide—brain cancer	0.000203	0.00196	CcSEcCtD
Candesartan—Dermatitis—Etoposide—brain cancer	0.000203	0.00196	CcSEcCtD
Candesartan—Headache—Etoposide—brain cancer	0.000202	0.00195	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RELA—brain cancer	0.000197	0.0095	CbGpPWpGaD
Candesartan—Nausea—Etoposide—brain cancer	0.000192	0.00185	CcSEcCtD
Candesartan—AGTR1—GPCR ligand binding—PTCH2—brain cancer	0.000187	0.00903	CbGpPWpGaD
Candesartan—PTGS1—Biological oxidations—CYP2C9—brain cancer	0.000184	0.0089	CbGpPWpGaD
Candesartan—AGTR1—G alpha (q) signalling events—TRPC6—brain cancer	0.000184	0.0089	CbGpPWpGaD
Candesartan—AGTR1—Arf6 signaling events—EGFR—brain cancer	0.00018	0.00871	CbGpPWpGaD
Candesartan—AGTR1—Arf6 trafficking events—CTNNB1—brain cancer	0.00018	0.00868	CbGpPWpGaD
Candesartan—PTGS1—pituitary gland—brain cancer	0.000178	0.0192	CbGeAlD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000175	0.00847	CbGpPWpGaD
Candesartan—CYP2C8—endocrine gland—brain cancer	0.00017	0.0183	CbGeAlD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000165	0.00796	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—OR4C12—brain cancer	0.000164	0.00792	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—OR14C36—brain cancer	0.000164	0.00792	CbGpPWpGaD
Candesartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000155	0.0075	CbGpPWpGaD
Candesartan—PTGS1—spinal cord—brain cancer	0.000153	0.0165	CbGeAlD
Candesartan—CYP2C9—endocrine gland—brain cancer	0.000151	0.0163	CbGeAlD
Candesartan—AGTR1—Signaling by GPCR—OR14C36—brain cancer	0.000149	0.00719	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—OR4C12—brain cancer	0.000149	0.00719	CbGpPWpGaD
Candesartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000138	0.00668	CbGpPWpGaD
Candesartan—PTGS1—endocrine gland—brain cancer	0.000138	0.0149	CbGeAlD
Candesartan—PTGS1—head—brain cancer	0.000136	0.0147	CbGeAlD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000134	0.00648	CbGpPWpGaD
Candesartan—ABCB1—telencephalon—brain cancer	0.000129	0.0139	CbGeAlD
Candesartan—PTGS1—central nervous system—brain cancer	0.000124	0.0134	CbGeAlD
Candesartan—AGTR1—Allograft Rejection—IL2—brain cancer	0.000123	0.00594	CbGpPWpGaD
Candesartan—CYP2C8—brain—brain cancer	0.000122	0.0131	CbGeAlD
Candesartan—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000119	0.00575	CbGpPWpGaD
Candesartan—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000117	0.00567	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	0.000113	0.00545	CbGpPWpGaD
Candesartan—ABCB1—gonad—brain cancer	0.000108	0.0116	CbGeAlD
Candesartan—ABCB1—pituitary gland—brain cancer	0.000105	0.0113	CbGeAlD
Candesartan—AGTR1—Allograft Rejection—VEGFA—brain cancer	0.000104	0.00504	CbGpPWpGaD
Candesartan—ABCB1—medulla oblongata—brain cancer	0.000102	0.0109	CbGeAlD
Candesartan—PTGS1—brain—brain cancer	9.88e-05	0.0106	CbGeAlD
Candesartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	9.69e-05	0.00468	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—SHH—brain cancer	9.64e-05	0.00465	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PTCH2—brain cancer	9.6e-05	0.00464	CbGpPWpGaD
Candesartan—ABCB1—midbrain—brain cancer	9.29e-05	0.01	CbGeAlD
Candesartan—AGTR1—GPCR ligand binding—SMO—brain cancer	9.14e-05	0.00441	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—PTCH1—brain cancer	9.14e-05	0.00441	CbGpPWpGaD
Candesartan—ABCB1—spinal cord—brain cancer	9.07e-05	0.00976	CbGeAlD
Candesartan—AGTR1—Signaling Pathways—OR14C36—brain cancer	8.8e-05	0.00425	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—OR4C12—brain cancer	8.8e-05	0.00425	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—ABR—brain cancer	8.3e-05	0.00401	CbGpPWpGaD
Candesartan—ABCB1—endocrine gland—brain cancer	8.16e-05	0.00879	CbGeAlD
Candesartan—ABCB1—head—brain cancer	8.06e-05	0.00868	CbGeAlD
Candesartan—AGTR1—Signaling by GPCR—ABR—brain cancer	7.53e-05	0.00364	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—DTX2—brain cancer	7.48e-05	0.00361	CbGpPWpGaD
Candesartan—ABCB1—central nervous system—brain cancer	7.36e-05	0.00792	CbGeAlD
Candesartan—ABCB1—cerebellum—brain cancer	7.19e-05	0.00774	CbGeAlD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.08e-05	0.00342	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—PDGFRA—brain cancer	6.61e-05	0.00319	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	6.53e-05	0.00315	CbGpPWpGaD
Candesartan—ABCB1—brain—brain cancer	5.84e-05	0.00629	CbGeAlD
Candesartan—AGTR1—Signaling Pathways—PTCH2—brain cancer	5.67e-05	0.00274	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CYP2C9—brain cancer	5.6e-05	0.0027	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	5.51e-05	0.00266	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HES5—brain cancer	5.49e-05	0.00265	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—STRADA—brain cancer	5.33e-05	0.00257	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—TRPC6—brain cancer	5.25e-05	0.00254	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	5.23e-05	0.00252	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.18e-05	0.0025	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—SHH—brain cancer	4.95e-05	0.00239	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—TRPC6—brain cancer	4.77e-05	0.0023	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—BSG—brain cancer	4.76e-05	0.0023	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PTCH1—brain cancer	4.69e-05	0.00226	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—SMO—brain cancer	4.69e-05	0.00226	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.57e-05	0.00221	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	4.57e-05	0.00221	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ABR—brain cancer	4.45e-05	0.00215	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	4.41e-05	0.00213	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GLI2—brain cancer	4.3e-05	0.00208	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	4.22e-05	0.00204	CbGpPWpGaD
Candesartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	4.13e-05	0.002	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—IDH1—brain cancer	4.09e-05	0.00198	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GLI1—brain cancer	4.04e-05	0.00195	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—VAV1—brain cancer	3.94e-05	0.0019	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SUFU—brain cancer	3.83e-05	0.00185	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GFAP—brain cancer	3.7e-05	0.00178	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	3.62e-05	0.00175	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL2—brain cancer	3.61e-05	0.00174	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—VAV1—brain cancer	3.57e-05	0.00173	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	3.55e-05	0.00172	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	3.54e-05	0.00171	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	3.51e-05	0.00169	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HEY1—brain cancer	3.5e-05	0.00169	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—DLL1—brain cancer	3.44e-05	0.00166	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.34e-05	0.00161	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.26e-05	0.00158	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ENO2—brain cancer	3.24e-05	0.00156	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP2C9—brain cancer	3.15e-05	0.00152	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	3.11e-05	0.0015	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—VEGFA—brain cancer	3.07e-05	0.00148	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SHH—brain cancer	2.92e-05	0.00141	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TRPC6—brain cancer	2.82e-05	0.00136	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PTCH1—brain cancer	2.77e-05	0.00134	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SMO—brain cancer	2.77e-05	0.00134	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.72e-05	0.00131	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.69e-05	0.0013	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—BSG—brain cancer	2.68e-05	0.00129	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.53e-05	0.00122	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PIK3CG—brain cancer	2.5e-05	0.00121	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—IDH1—brain cancer	2.31e-05	0.00111	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CG—brain cancer	2.27e-05	0.0011	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NOTCH2—brain cancer	2.21e-05	0.00107	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.11e-05	0.00102	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—VAV1—brain cancer	2.11e-05	0.00102	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP2C9—brain cancer	2.04e-05	0.000983	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.96e-05	0.000948	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.88e-05	0.000906	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ENO2—brain cancer	1.82e-05	0.00088	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HES1—brain cancer	1.82e-05	0.000877	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP2C9—brain cancer	1.77e-05	0.000857	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—IL2—brain cancer	1.76e-05	0.000849	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.74e-05	0.000838	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—BSG—brain cancer	1.73e-05	0.000836	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PDGFRA—brain cancer	1.73e-05	0.000835	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.72e-05	0.00083	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SPP1—brain cancer	1.68e-05	0.00081	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL2—brain cancer	1.6e-05	0.000771	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IRS2—brain cancer	1.52e-05	0.000733	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.51e-05	0.000731	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—BSG—brain cancer	1.51e-05	0.000729	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—IDH1—brain cancer	1.49e-05	0.000719	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CG—brain cancer	1.48e-05	0.000717	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—BSG—brain cancer	1.41e-05	0.000681	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.39e-05	0.000672	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.36e-05	0.000657	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CG—brain cancer	1.34e-05	0.000647	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—APC—brain cancer	1.34e-05	0.000647	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—IDH1—brain cancer	1.3e-05	0.000626	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—EGFR—brain cancer	1.22e-05	0.00059	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.21e-05	0.000586	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—IDH1—brain cancer	1.21e-05	0.000585	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ENO2—brain cancer	1.18e-05	0.000568	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.14e-05	0.000552	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—RELA—brain cancer	1.05e-05	0.000506	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ERBB2—brain cancer	1.04e-05	0.000503	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ENO2—brain cancer	1.03e-05	0.000495	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.87e-06	0.000477	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ENO2—brain cancer	9.58e-06	0.000463	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL2—brain cancer	9.43e-06	0.000455	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCND1—brain cancer	9.19e-06	0.000444	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CTNNB1—brain cancer	9.11e-06	0.00044	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CG—brain cancer	8.36e-06	0.000404	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—VEGFA—brain cancer	8.02e-06	0.000387	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—STAT3—brain cancer	7.94e-06	0.000383	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MYC—brain cancer	7.38e-06	0.000356	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EGFR—brain cancer	7.21e-06	0.000348	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TP53—brain cancer	6.06e-06	0.000292	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CG—brain cancer	5.4e-06	0.000261	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CG—brain cancer	4.7e-06	0.000227	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CG—brain cancer	4.39e-06	0.000212	CbGpPWpGaD
